Gaziantep University   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Gaziantep Turkey (1987)

Organization Overview

First Clinical Trial
2008
NCT02343432
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Gaziantep | Gaziantep Islamic Science and Technology University faculty of health sciences | Gaziantep Islamic University of Science and Technology | Gaziantep Islam Science and Technology University | Gaziantep University Biochemistry Department | Gaziantep University Medical Faculty | Gaziantep University Periodontology Department | Semra Çevik, phD | University of Gaziantep | Yasemin ATEŞEYAN

Active Ingredients

Drugs in Phase 4 Trials (4)

acetaminophen (tylenol) (1 trial)

morphine (1 trial)

oxybutynin (ditropan) (1 trial)

solifenacin (vesicare) (1 trial)

Drugs in Phase 3 Trials (1)

secukinumab (cosentyx) (1 trial)

Drugs in Phase 1 Trials (1)

umbilical cord mesenchymal stem cells (1 trial)

Drugs in Other Trials (2)

levobupivacaine (chirocaine) (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Muscular Dystrophies (Phase 1)

Muscular Dystrophy, Duchenne (Phase 1)

Psoriasis (Phase 3)

Sciatica (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8